246 related articles for article (PubMed ID: 33804129)
21. Multi-Targeted Molecular Docking and Drug-Likeness Evaluation of some Nitrogen Heterocyclic Compounds Targeting Proteins Involved in the Development of COVID-19.
Hui LY; Mun CS; Sing LC; Rajak H; Karunakaran R; Ravichandran V
Med Chem; 2023; 19(3):297-309. PubMed ID: 35713125
[TBL] [Abstract][Full Text] [Related]
22. Revealing the Inhibition Mechanism of RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2 by Remdesivir and Nucleotide Analogues: A Molecular Dynamics Simulation Study.
Wakchaure PD; Ghosh S; Ganguly B
J Phys Chem B; 2020 Nov; 124(47):10641-10652. PubMed ID: 33190493
[TBL] [Abstract][Full Text] [Related]
23. Aurasperone A Inhibits SARS CoV-2 In Vitro: An Integrated In Vitro and In Silico Study.
ElNaggar MH; Abdelwahab GM; Kutkat O; GabAllah M; Ali MA; El-Metwally MEA; Sayed AM; Abdelmohsen UR; Khalil AT
Mar Drugs; 2022 Feb; 20(3):. PubMed ID: 35323478
[TBL] [Abstract][Full Text] [Related]
24. Computational Determination of Potential Multiprotein Targeting Natural Compounds for Rational Drug Design Against SARS-COV-2.
Muhseen ZT; Hameed AR; Al-Hasani HMH; Ahmad S; Li G
Molecules; 2021 Jan; 26(3):. PubMed ID: 33525411
[TBL] [Abstract][Full Text] [Related]
25. Molecular screening of antimalarial, antiviral, anti-inflammatory and HIV protease inhibitors against spike glycoprotein of coronavirus.
Prashantha CN; Gouthami K; Lavanya L; Bhavanam S; Jakhar A; Shakthiraju RG; Suraj V; Sahana KV; Sujana HS; Guruprasad NM; Ramachandra R
J Mol Graph Model; 2021 Jan; 102():107769. PubMed ID: 33152616
[TBL] [Abstract][Full Text] [Related]
26. Proposal of novel natural inhibitors of severe acute respiratory syndrome coronavirus 2 main protease: Molecular docking and ab initio fragment molecular orbital calculations.
Shaji D; Yamamoto S; Saito R; Suzuki R; Nakamura S; Kurita N
Biophys Chem; 2021 Aug; 275():106608. PubMed ID: 33962341
[TBL] [Abstract][Full Text] [Related]
27. A computational evaluation of targeted oxidation strategy (TOS) for potential inhibition of SARS-CoV-2 by disulfiram and analogues.
Xu L; Tong J; Wu Y; Zhao S; Lin BL
Biophys Chem; 2021 Sep; 276():106610. PubMed ID: 34089978
[TBL] [Abstract][Full Text] [Related]
28. Key genetic elements, single and in clusters, underlying geographically dependent SARS-CoV-2 genetic adaptation and their impact on binding affinity for drugs and immune control.
Salpini R; Alkhatib M; Costa G; Piermatteo L; Ambrosio FA; Di Maio VC; Scutari R; Duca L; Berno G; Fabeni L; Alcaro S; Ceccherini-Silberstein F; Artese A; Svicher V
J Antimicrob Chemother; 2021 Jan; 76(2):396-412. PubMed ID: 33254234
[TBL] [Abstract][Full Text] [Related]
29. Integrated bioinformatics-cheminformatics approach toward locating pseudo-potential antiviral marine alkaloids against SARS-CoV-2-Mpro.
Swain SS; Singh SR; Sahoo A; Panda PK; Hussain T; Pati S
Proteins; 2022 Sep; 90(9):1617-1633. PubMed ID: 35384056
[TBL] [Abstract][Full Text] [Related]
30. Emetine, a potent alkaloid for the treatment of SARS-CoV-2 targeting papain-like protease and non-structural proteins: pharmacokinetics, molecular docking and dynamic studies.
Snoussi M; Redissi A; Mosbah A; De Feo V; Adnan M; Aouadi K; Alreshidi M; Patel M; Kadri A; Noumi E
J Biomol Struct Dyn; 2022; 40(20):10122-10135. PubMed ID: 34254564
[TBL] [Abstract][Full Text] [Related]
31. An Updated Review on SARS-CoV-2 Main Proteinase (M
Sabbah DA; Hajjo R; Bardaweel SK; Zhong HA
Curr Top Med Chem; 2021; 21(6):442-460. PubMed ID: 33292134
[TBL] [Abstract][Full Text] [Related]
32. Structure-based screening of novel lichen compounds against SARS Coronavirus main protease (Mpro) as potentials inhibitors of COVID-19.
Joshi T; Sharma P; Joshi T; Pundir H; Mathpal S; Chandra S
Mol Divers; 2021 Aug; 25(3):1665-1677. PubMed ID: 32602074
[TBL] [Abstract][Full Text] [Related]
33. In silico study of the potential interactions of 4'-acetamidechalcones with protein targets in SARS-CoV-2.
Q Almeida-Neto FW; Castro Matos MG; Marinho EM; Marinho MM; Róseo Paula Pessoa Bezerra de Menezes R; Sampaio TL; Bandeira PN; Celedonio Fernandes CF; Magno Rodrigues Teixeira A; Marinho ES; de Lima-Neto P; Silva Dos Santos H
Biochem Biophys Res Commun; 2021 Jan; 537():71-77. PubMed ID: 33387885
[TBL] [Abstract][Full Text] [Related]
34. Protease targeted COVID-19 drug discovery: What we have learned from the past SARS-CoV inhibitors?
Amin SA; Banerjee S; Gayen S; Jha T
Eur J Med Chem; 2021 Apr; 215():113294. PubMed ID: 33618158
[TBL] [Abstract][Full Text] [Related]
35. Is oseltamivir suitable for fighting against COVID-19: In silico assessment, in vitro and retrospective study.
Tan Q; Duan L; Ma Y; Wu F; Huang Q; Mao K; Xiao W; Xia H; Zhang S; Zhou E; Ma P; Song S; Li Y; Zhao Z; Sun Y; Li Z; Geng W; Yin Z; Jin Y
Bioorg Chem; 2020 Nov; 104():104257. PubMed ID: 32927129
[TBL] [Abstract][Full Text] [Related]
36. Tomatidine and Patchouli Alcohol as Inhibitors of SARS-CoV-2 Enzymes (3CLpro, PLpro and NSP15) by Molecular Docking and Molecular Dynamics Simulations.
Zrieq R; Ahmad I; Snoussi M; Noumi E; Iriti M; Algahtani FD; Patel H; Saeed M; Tasleem M; Sulaiman S; Aouadi K; Kadri A
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639036
[TBL] [Abstract][Full Text] [Related]
37. Novel adenosine derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective.
Sonousi A; Mahran HA; Ibrahim IM; Ibrahim MN; Elfiky AA; Elshemey WM
Pharmacol Rep; 2021 Dec; 73(6):1754-1764. PubMed ID: 34165771
[TBL] [Abstract][Full Text] [Related]
38. Zinc and SARS‑CoV‑2: A molecular modeling study of Zn interactions with RNA‑dependent RNA‑polymerase and 3C‑like proteinase enzymes.
Pormohammad A; Monych NK; Turner RJ
Int J Mol Med; 2021 Jan; 47(1):326-334. PubMed ID: 33236142
[TBL] [Abstract][Full Text] [Related]
39. Natural Products-Based Drug Design against SARS-CoV-2 Mpro 3CLpro.
Silva RC; Freitas HF; Campos JM; Kimani NM; Silva CHTP; Borges RS; Pita SSR; Santos CBR
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769170
[TBL] [Abstract][Full Text] [Related]
40. In vitro biological evaluation and in silico insights into the antiviral activity of standardized olive leaves extract against SARS-CoV-2.
Majrashi TA; El Hassab MA; Mahmoud SH; Mostafa A; Wahsh EA; Elkaeed EB; Hassan FE; Eldehna WM; Abdelgawad SM
PLoS One; 2024; 19(4):e0301086. PubMed ID: 38662719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
